Stay updated on Maintenance Therapy Trial: Odetiglucan & CD40 Agonist

Sign up to get notified when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.
Latest website image capture
Clouds background image

Latest updates to the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    - The study page now shows a 403 Forbidden error, replacing the full trial details with an access-denied message. This makes the core information about the study unavailable to users.
    Difference
    19%
    Check dated 2026-09-20T08:50:41.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.6) replacing the previous v3.6.5, indicating a small platform update. No substantive study content appears to be changed.
    Difference
    0.1%
    Check dated 2026-08-29T23:40:19.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a minor metadata update to the study record without altering its content.
    Difference
    0.1%
    Check dated 2026-08-08T23:45:03.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision tag on the page was updated from v3.6.3 to v3.6.4, indicating an administrative update to the study record rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-25T13:19:59.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.2 to v3.6.3, indicating a minor update to the study record.
    Difference
    0.1%
    Check dated 2026-07-03T23:58:27.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.0 to v3.6.2, representing a maintenance update to the ClinicalTrials.gov page; no substantive changes to the study details are indicated.
    Difference
    0.1%
    Check dated 2026-06-26T23:31:59.000Z thumbnail image

Stay in the know with updates to Maintenance Therapy Trial: Odetiglucan & CD40 Agonist

Enter your email address, and we'll notify you when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.